Skip to content

Buteyko Based Remedial Breathing Therapy With Children With Asthma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02140086
Enrollment
32
Registered
2014-05-16
Start date
2014-01-31
Completion date
2014-11-30
Last updated
2016-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

asthma, Buteyko, remedial breathing, children

Brief summary

A randomized, controlled trial to investigate the effects of a buteyko based remedial breathing therapy on children with asthma regarding to their symptoms, use of medication and lung function tests.

Interventions

BEHAVIORALButeyko based Remedial Breathing Therapy

Buteyko based remedial Breathing Therapy after Dr. Buteyko

Sponsors

ARCIM Institute Academic Research in Complementary and Integrative Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 15 Years
Healthy volunteers
Yes

Inclusion criteria

* signed informed consent of the parents * age 6- 15 years * information and consent of the consulting doctor * levels of asthma therapy 1-3

Exclusion criteria

* participation in another study

Design outcomes

Primary

MeasureTime frame
Reduction of Betamimetics (-30%) at 3- and/or 6-month follow upasthmaspezific parameters are measured before and after intervention as well as 3- and 6- month follow up

Secondary

MeasureTime frameDescription
Paediatric Asthma Quality of Life Questionnaire (PAQLQ)parameters are measured before and after intervention as well as 3- and 6- month follow upScores of PAQLQ (Paediatric Asthma Quality of Life Questionnaire)
ARCIM Questionnaire (AFB)parameters are measured before and after intervention as well as 3- and 6- month follow upScores of the AFB (ARCIM Questionnaire) regarding to asthma symptoms of the last 3 month (AFB is not validated)
Peak Flowparameters are measured before and after intervention as well as 3- and 6- month follow up
Asthma Control Questionnaire (ACQ)parameters are measured before and after intervention as well as 3- and 6- month follow upScores of the ACQ (Asthma Control Questionnaire)
Buteyko-Questionnaireparameters are measured before and after intervention as well as 3- and 6- month follow up
parameters of spirometryparameters are measured before and after intervention as well as 3- and 6- month follow up
Paediatric asthma caregiver´s quality of life questionnaire (PACQLQ)parameters are measured before and after intervention as well as 3- and 6- month follow up
NO-measurement nasal and oralparameters are measured before and after intervention as well as 3- and 6- month follow up

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026